The Gross Margin of Inari Medical Inc (NARI) is
88.03%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date |
Value |
| 2023-12-31 |
88.03%
|
| 2022-12-31 |
88.40%
|
| 2021-12-31 |
91.05%
|
| 2020-12-31 |
90.69%
|
| 2019-12-31 |
88.65%
|
| 2018-12-31 |
80.88%
|
| Ticker |
Name |
Value |
|
AXNX
|
Axonics Inc
|
74.94%
|
|
CNMD
|
Conmed Corp
|
53.87%
|
|
GKOS
|
Glaukos Corporation
|
77.97%
|
|
GNMK
|
Genmark Diagnostics Inc
|
39.61%
|
|
LIVN
|
LivaNova PLC
|
67.71%
|
|
AXGN
|
AxoGen, Inc.
|
74.31%
|
|
SWAV
|
Shockwave Medical Inc
|
86.94%
|
|
TCMD
|
Tactile Systems Technology, Inc.
|
50.79%
|
|
TNDM
|
Tandem Diabetes Care, Inc.
|
53.81%
|
|
INMD
|
InMode Ltd.
|
78.54%
|
|
NNOX
|
Nano-X Imaging Ltd
|
-98.21%
|
|
OM
|
Outset Medical, Inc.
|
39.13%
|
|
ATEC
|
Alphatec Holdings, Inc.
|
69.60%
|
|
ATRC
|
AtriCure, Inc.
|
74.98%
|
|
EAR
|
Eargo Inc
|
38.28%
|
|
HSKA
|
Heska Corp
|
43.20%
|
|
IART
|
Integra LifeSciences Holdings Corporation
|
56.62%
|
|
INGN
|
Inogen, Inc.
|
44.24%
|
|
NUVA
|
NuVasive Inc
|
72.00%
|
|
NVRO
|
Nevro LLC
|
66.37%
|
|
CSII
|
Cardiovascular Systems Inc
|
73.14%
|
|
GMED
|
Globus Medical, Inc.
|
67.41%
|
|
PEN
|
Penumbra, Inc.
|
67.14%
|
|
CMD
|
Cantel Medical Corp
|
45.53%
|
|
LMAT
|
LeMaitre Vascular, Inc.
|
71.53%
|
|
MLAB
|
Mesa Laboratories, Inc.
|
63.53%
|
|
CRY
|
Artivion Inc
|
6625.83%
|
|
ITGR
|
Integer Holdings Corp
|
27.39%
|